Cloud Ml

Nizatidine versus placebo in gastro-oesophageal reflux disease: a 6-week, multicentre, randomised, double-blind comparison. Nizatidine Gastroesophageal Reflux Disease Study Group.

Cloud Ml, Offen Ww, 1994 .

Nizatidine versus placebo in gastroesophageal reflux disease: a 12-week, multicenter, randomized, double-blind study.

W. Offen, M. Robinson, M. Cloud, 1991, The American journal of gastroenterology.